Sage Therapeutics sponsored trial for Parkinson’s Disease Mild Cognitive Impairment (PD-MCI)

Sage Therapeutics sponsored trial for Parkinson’s Disease Mild Cognitive Impairment (PD-MCI): Research study for adults ages 50 to 75 years old who have been diagnosed with PD-MCI. The purpose of this study is to evaluate the safety and tolerability of an investigational medication. Participants must have a confirmed diagnosis of PD-MCI. The study is currently enrolling at the following sites:

• Long Beach, CA – Collaborative Neuroscience Network – Long Beach
• Port Charlotte, FL – Parkinson’s Disease Treatment Center of Southwest Florida
• West Palm Beach, FL – Palm Beach Neurology and Premiere Research Institute

For additional information on the PARADIGM STUDY, please visit the trial listing on clinicaltrials.gov or contact clinicaltrialsinquiry@sagerx.com.